文献速递皮肤肿瘤

临床无色素性黑色素瘤与色素性黑色素瘤的临床病理、误诊及生存差异

Clinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomas.
PubMed 文献 · J Am Acad Dermatol · 2019-01-14

一项在三级学术医疗中心开展的回顾性横断面病历审查,纳入933例已知就诊时肿瘤颜色的黑色素瘤患者(无色素性黑色素瘤342例 vs 色素性黑色素瘤591例)。无色素性黑色素瘤与年龄较大、非黑色素瘤皮肤癌史及红发相关,且更易位于头颈部、具有更具侵袭性的病理特征、更易被误诊,黑色素瘤特异性生存更差。

要点

  • 无色素性黑色素瘤与年龄较大、非黑色素瘤皮肤癌史及红发相关。
  • 无色素性黑色素瘤更易位于头颈部,且Breslow深度更大、核分裂更多、溃疡及结节型更常见。
  • 无色素性黑色素瘤临床误诊率25% vs 色素性12%,病理误诊率12% vs 7%,5年总生存率0.77 vs 0.84。

核心结论

  • 提高临床医生警觉性、降低活检阈值及加强患者教育可能有助于在具有特定特征的患者中提高无色素性黑色素瘤的检出。

研究设计与样本

  • 在三级学术医疗中心开展的回顾性横断面病历审查,共纳入933例已知就诊时肿瘤颜色的黑色素瘤患者,其中无色素性黑色素瘤342例,色素性黑色素瘤591例。

主要发现

  • 无色素性黑色素瘤与年龄较大、非黑色素瘤皮肤癌史及红发相关,而与黑色素瘤家族史、超过50个痣及发育不良痣史呈负相关。
  • 与色素性黑色素瘤相比,无色素性黑色素瘤更常位于头部和/或颈部,并具有更具侵袭性的病理特征(Breslow深度更大和/或核分裂、溃疡、结节型)。
  • 无色素性黑色素瘤较少与 precursor nevus 或消退相关。
  • 无色素性黑色素瘤患者临床误诊率25% vs 色素性黑色素瘤12%,病理误诊率12% vs 7%。
  • 无色素性黑色素瘤患者黑色素瘤特异性生存更差,5年总生存率0.77(95%CI 0.72-0.82) vs 色素性黑色素瘤0.84(95%CI 0.80-0.87)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 回顾性研究设计。
  • 单机构研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Amelanotic malignant melanoma (AMM) is challenging to diagnose. Clinical risk factors for AMM are not well defined. OBJECTIVE: To investigate clinicopathologic, misdiagnosis, and survival differences between patients with AMM and those with pigmented malignant melanoma (PMM). METHODS: A cross-sectional retrospective medical record review at a tertiary academic medical center. RESULTS: A total of 933 patients with melanoma with known presenting tumor color were identified (342 with AMM vs 591 with PMM). AMM was associated with older age, history of nonmelanoma skin cancer, and red hair, whereas AMM was inversely associated with a family history of melanoma, more than 50 nevi, and a history of dysplastic nevi. Compared with PMM, AMM was more likely to be located on the head and/or neck, had more aggressive pathologic features (greater Breslow depth and/or mitoses, ulceration, nodular subtype), and was less likely to be associated with a precursor nevus or regression. Finally, patients with AMM were more likely to be misdiagnosed than were patients with PMM (25% vs 12% clinically and 12% vs 7% pathologically), and they had poorer melanoma-specific survival (5-year overall survival rate, 0.77 [95% confidence interval, 0.72-0.82] vs 0.84 [95% confidence interval, 0.80-0.87]). LIMITATIONS: Retrospective study design, single-institutional study. CONCLUSION: Greater clinician awareness, lower biopsy thresholds, and increased patient education may be useful to enhance AMM detection in patients with certain characteristics.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Strazzulla LC, Li X, Zhu K, et al. Clinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomas. J Am Acad Dermatol. 2019. PMID: 30654075. doi:10.1016/j.jaad.2019.01.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。